zanamivir has been researched along with caprylates in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikematsu, H; Kawai, N | 1 |
| Feng, E; Gao, F; Gao, GF; He, J; Jiang, H; Li, Q; Liu, H; Liu, J; Liu, Y; Qi, J; Vavricka, CJ; Wang, J; Wang, M; Wu, Y | 1 |
1 review(s) available for zanamivir and caprylates
| Article | Year |
|---|---|
Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
Topics: Administration, Inhalation; Adult; Animals; Antiviral Agents; Birds; Caprylates; Child; Drug Resistance, Viral; Enzyme Inhibitors; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza in Birds; Influenza, Human; Japan; Neuraminidase; Oseltamivir; Prodrugs; Pyrans; Sialic Acids; Viral Proteins; Virus Replication; Zanamivir | 2011 |
1 other study(ies) available for zanamivir and caprylates
| Article | Year |
|---|---|
Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition.
Topics: Antiviral Agents; Caprylates; Catalytic Domain; Drug Resistance, Viral; Enzyme Inhibitors; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Inhibitory Concentration 50; Neuraminidase; Oseltamivir; Prodrugs; Pyrans; Sialic Acids; Zanamivir | 2011 |